FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
SYVA EMIT 2000 THYROXINE ASSAY, CALIBRATORS
K Number: K000600
·
Decision Mar 27, 2000
Classifications
1
FEI Numbers
45
Registration Numbers
45
Same Product Code
85
Applicant Total
19
Review Days
33
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- SYVA EMIT 2000 THYROXINE ASSAY, CALIBRATORS
- K Number
- K000600
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.1700
- Medical Specialty
- Clinical Chemistry
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Syva Co., Dade Behring, Inc.
- Date Received
- February 23, 2000
- Decision Date
- March 27, 2000
- Product Code
- KLI
- Advisory Committee
- Clinical Chemistry
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| KLI | Enzyme Immunoassay, Non-Radiolabeled, Total Thyroxine | FDA class 2 | Clinical Chemistry |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (KLI), ordered by most recent decision date.
VITROS® Automation Solutions
FDA 510(k)
FDA Class 2
·Clinical Chemistry
ACE -GT REAGENT; ACE LIPASE RAGENT; ACE T4 REAGENT
FDA 510(k)
FDA Class 2
·Clinical Chemistry
GSP NEONATAL THYROXINE (T4)
FDA 510(k)
FDA Class 2
·Clinical Chemistry
ADVIA CENTAUR SYSTEM WITH STREAMLAB ANALYTICAL WORKCELL
FDA 510(k)
FDA Class 2
·Clinical Chemistry
ACCUBIND NEONATAL T4 MICROPLATE EIA, MODEL 2625-300
FDA 510(k)
FDA Class 2
·Clinical Chemistry
ACCESS TOTAL T4 ASSAY
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Other Clearances by Syva Co., Dade Behring, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K011920 | EMIT 2000 DIGOXIN ASSAY, MODEL OSR4H229 | Jul 2, 2001 | Substantially Equivalent |
| K011620 | EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N229 | Jun 18, 2001 | Substantially Equivalent |
| K011605 | EMIT 2000 QUINIDINE ASSAY, MODEL OSR4Q229 | Jun 12, 2001 | Substantially Equivalent |
| K011300 | EMIT II PLUS CANNABINOID ASSAY, MODEL OSR9N229 | May 17, 2001 | Substantially Equivalent |
| K011306 | EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F229 | May 16, 2001 | Substantially Equivalent |
| K011161 | MODIFICATION TO THE EMIT II PLUS PHENCYCLIDINE ASSAY, MODEL OSR9J229 | May 15, 2001 | Substantially Equivalent |
| K011289 | EMIT II PLUS OPIATE ASSAY, MODEL OSR9B229 | May 15, 2001 | Substantially Equivalent |
| K011163 | MODIFICATION TO THE EMIT II PLUS PROPOXYPHENE ASSAY, MODEL OSR9G229 | May 10, 2001 | Substantially Equivalent |
| K011166 | MODIFICATION TO EMIT 2000 THEOPHYLLINE ASSAY, MODEL OSR 4P229 | May 10, 2001 | Substantially Equivalent |
| K011164 | MODIFICATION TO THE EMIT II PLUS METHAQUALONE ASSAY, MODEL OSR9Q229 | May 10, 2001 | Substantially Equivalent |